You are here: Industry Insights > teva

News List

US charges Teva in price-fixing investigation of generic drugs expresspharma
August 27, 2020
The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used pharma products, including a high cholesterol drug.
Teva enters biosimilar commercialisation partnership with Alvotech pharmaceutical-technology
August 06, 2020
Israel-based Teva Pharmaceutical has formed an exclusive strategic collaboration with Alvotech to commercialise five biosimilar candidates in the US.
Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko pharmaceutical-technology
August 03, 2020
A business joint venture (BV) comprising Teva Pharmaceutical and Takeda Pharmaceutical in Japan is set to divest the majority of its generic and operational assets to Nichi-Iko Pharmaceutical.
Teva Initiates Recall of Metformin Hydrochloride Extended-Release Tablets americanpharmaceuticalreview
June 18, 2020
Teva Pharmaceuticals is voluntarily recalling fourteen (14) lots of Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, 100 and 1000 count bottles ...
Teva Partners with Schreiner MediPharm for Novel Adrenaline Injector Label contractpharma
June 16, 2020
Multi-functional specialty label keeps product and user information visible.
NICE publishes final guidance backing Teva's Ajovy for migraine pharmatimes
June 05, 2020
The National Institute for Health and Care Excellence (NICE) has now published final guidelines endorsing the NHS use of Teva’s Ajovy (fremanezumab) to prevent migraine.
MHRA issues Medicines Defect Information alert for levofloxacin tablets europeanpharmaceuticalreview
April 20, 2020
Teva has informed the MHRA that the GTIN number found on a batch of levofloxacin tablets is incorrect, prompting the Medicines Defect Information alert.
Teva Donates Potential COVID-19 Treatment to Hospitals Nationwide contractpharma
March 23, 2020
Will give 6 million tablets through wholesalers to hospitals by March 31, and more than 10 million within a month.
Ajovy bags NICE approval pharmatimes
March 13, 2020
The National Institute for Health and Care Excellence (NICE) has recommended Teva’s Ajovy for the prophylaxis of migraine in adults with chronic migraine who have not responded to at least three prior preventive treatments.
Teva’s Austedo flunks in late-stage paediatric Tourette study pharmatimes
March 10, 2020
Teva has announced that Austedo (deutetrabenazine) failed to meet its primary endpoints of reduction in motor and phonic tics in moderate-to-severe paediatric Tourette syndrome.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page